Approaches to SARS-CoV-2 and other vaccinations in children with a history of multisystem inflammatory syndrome (MIS-C): An international survey
BackgroundFollowing the Coronavirus Disease-19 (COVID-19) pandemic outbreaks, the hyperinflammatory condition termed Multisystem Inflammatory Syndrome in Children (MIS-C) became a healthcare issue worldwide. Since December 2020 the mRNA vaccine against SARS-CoV-2 has become available with a good saf...
Main Authors: | Francesca Minoia, Federica Lucioni, Merav Heshin-Bekenstein, Sebastiaan Vastert, Christoph Kessel, Yosef Uziel, Lovro Lamot, Nicolino Ruperto, Marco Gattorno, Claudia Bracaglia, Natasa Toplak |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-11-01
|
Series: | Frontiers in Pediatrics |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fped.2022.1030083/full |
Similar Items
-
The Role of Glucocorticoids in the Treatment of Multisystem Inflammatory Syndrome (MIS-C)—Data from POLISH MIS-C Registry
by: Ewelina Gowin, et al.
Published: (2022-02-01) -
Best Practice Recommendations for the Diagnosis and Management of Children With Pediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2 (PIMS-TS; Multisystem Inflammatory Syndrome in Children, MIS-C) in Switzerland
by: Luregn J. Schlapbach, et al.
Published: (2021-05-01) -
Multisystem inflammatory syndrome in children (MIS-C) and the coronavirus pandemic: Current knowledge and implications for public health
by: Megan S. Rafferty, et al.
Published: (2021-04-01) -
Enigma of COVID-19: is “multisystem inflammatory syndrome in adults” (MIS-A) predictable?
by: Istemi Serin, et al.
Published: (2022-03-01) -
Rapid review of multisystem inflammatory syndrome in paediatrics: What we know one year later
by: Megan Striha, et al.
Published: (2021-11-01)